Aaron M Lazorwitz
Yale University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Aaron M Lazorwitz as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:45 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT06334315 · Oral Contraceptive Pill (OCP) PharmacogenomicsYale University · recruiting · Contraception, Pharmacogenomic Drug Interaction · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Influence of genetic variants on the pharmacokinetics and pharmacodynamics of combined oral contraceptive pill usersR01HD111436 · NICHD · YALE UNIVERSITY · fiscal years 2024 to 2026 · $657,921 awarded in 2026Grant number is on one of their registry trials
- Prospective long-term study of etonogestrel contraceptive implant insertion at an alternative scapular siteR56HD117869 · NICHD · YALE UNIVERSITY · fiscal years 2025 · $1,295,474 awarded in 2025Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.